Monkey Pox Treatment Market to Reach $0.16 Billion by 2029, Growing at a CAGR of 13%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Monkey Pox Treatment Industry In 2025?

The monkey pox treatment market has experienced rapid expansion in recent years. It is anticipated to increase from $0.09 billion in 2024 to $0.1 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.6%. This historical growth can be attributed to outbreaks in endemic regions, heightened awareness of zoonotic transmission, the lasting impact of smallpox eradication, various public health initiatives, and the appearance of human cases.

The monkeypox treatment market size is anticipated to undergo significant growth over the next few years. It is projected to expand to $0.16 billion by 2029, achieving a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is primarily driven by factors such as increased globalization and travel, government funding and support, investment from biotech and pharmaceutical sectors, public health surveillance efforts, and regulatory approvals. Significant trends expected in the forecast period involve the advancement of antiviral drugs, the deployment of smallpox vaccines, the use of monoclonal antibodies, the development of combination therapies, and studies focused on long-term immunity.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18818&type=smp

What Are The Top Growth Drivers Impacting The Monkey Pox Treatment Market Outlook?

The anticipated expansion of the monkeypox treatment market is largely attributed to the growing occurrence of zoonotic infections. Zoonotic infections are illnesses passed from animals to humans, typically through direct interaction with contaminated surroundings or via vectors. Heightened human-animal interaction, which brings individuals and animals into closer proximity, consequently elevates the danger of zoonotic infections. Furthermore, climate change exacerbates this hazard by extending the habitats of disease vectors and introducing pathogens into previously unaffected regions. Monkeypox treatments play a crucial role in managing zoonotic mpox, working to target the virus and mitigate symptoms in both humans and animals that may be infected. An illustrative example comes from August 2024, where a report from the UK Health Security Agency, a government body in the UK, indicated 3,732 confirmed mpox cases in the UK, with an increase of 21 cases in 2023, bringing the total to 3753 cases for that year. Consequently, the growing incidence of zoonotic infections serves as a key driver for the monkeypox treatment market.

How Is The Monkey Pox Treatment Market Classified Into Different Segments?

The monkey pox treatmentmarket covered in this report is segmented –

1) By Treatment Type: Prophylactic Vaccines; Therapeutics

2) By Dosage Forms: Solid; Liquid; Semi Solid

3) By Route Of Administration: Oral; Topical; Parenteral

4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies

Subsegments:

1) By Prophylactic Vaccines: Vaccinia-Based Vaccines; Modified Vaccinia Ankara (MVA) Vaccines; Other Vaccines (Recombinant Vaccines)

2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir); Immune Modulators; Supportive Care Treatments

Which Trends Are Impacting The Monkey Pox Treatment Market?

Companies active in the monkeypox treatment market are concentrating on remote monitoring and teletherapy options, such as virtual care, to improve accessibility, simplify patient management, and achieve better treatment results. Virtual care for monkeypox treatment offers remote medical consultations, symptom assessment, and management plans for individuals who are at risk or infected, thereby easing access to healthcare and reducing the need for physical visits. For example, in August 2022, Folx Health, a US-based healthcare company, launched Monkeypox Care, providing virtual primary care services for those susceptible to or impacted by monkeypox. This service employs a thorough strategy that encompasses education, counseling, symptom evaluation, and referrals. The initiative is intended to reach people in “care deserts”—areas where healthcare access is limited—ensuring that quality information and referral services are available to everyone, regardless of where they live.

Who Are The Top Performing Companies In The Monkey Pox Treatment Market In Recent Years?

Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

What Are The Regional Market Dynamics Impacting The Monkey Pox Treatment Industry?

North America was the largest region in the monkey pox treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Monkey Pox Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18818&type=smp

Browse Through More Reports Similar to the Global Monkey Pox Treatment Market 2025, By The Business Research Company

Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Control Supplies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Infection Prevention Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795